Back to trial details

Intake questionnaire

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Applying to University of Illinois Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Patients With Non-Small Cell Lung Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?